Back

YieldMax Short TSLA Option Income Strategy ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell

CRSH
YieldMax Short TSLA Option Income Strategy ETF

Last Price:

$24.90

Seasonality Move:

-15.4%

Buy

GPCR
Structure Therapeutics, Inc.

Last Price:

$69.34

Seasonality Move:

-34.19%

Sell

YieldMax Short TSLA Option Income Strategy ETF (CRSH) is a Sell

Is YieldMax Short TSLA Option Income Strategy ETF a Buy, Sell or Hold?

The current YieldMax Short TSLA Option Income Strategy ETF [CRSH] share price is $24.31. The Score for CRSH is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
CRSH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CRSH Stock Price Chart

What is YieldMax Short TSLA Option Income Strategy ETF's stock price today?

The YieldMax Short TSLA Option Income Strategy ETF share price today is $24.31

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSH is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

The Structure Therapeutics, Inc. share price today is $71.29

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSH Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.21	Sell
Relative Strength Index (14 RSI):	32.08	Sell
Chaikin Money Flow:	12864	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(25.27 - 29.23)	Sell
Bollinger Bands (100):	(26.77 - 38.25)	Sell

GPCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	8.5	Buy
Relative Strength Index (14 RSI):	72.85	Buy
Chaikin Money Flow:	1903413	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(33.41 - 65.27)	Buy
Bollinger Bands (100):	(17 - 45.24)	Buy

CRSH Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	25.12	Sell
20-day SMA:	26.51	Sell
50-day SMA:	28.22	Sell
200-day SMA:	44.78	Sell
8-day EMA:	25.1	Sell
20-day EMA:	26.3	Sell
50-day EMA:	28.54	Sell
200-day EMA:	48.37	Sell

GPCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	64.43	Buy
20-day SMA:	52.92	Buy
50-day SMA:	40.28	Buy
200-day SMA:	26.09	Buy
8-day EMA:	64	Buy
20-day EMA:	55.88	Buy
50-day EMA:	44.22	Buy
200-day EMA:	31.26	Buy

YieldMax Short TSLA Option Income Strategy ETF Earnings Growth & CRSH Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

YieldMax Short TSLA Option Income Strategy ETF Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22
	Dec
	09	10	11	12	15	16	17	18	19	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23
	Dec
	10	11	12	15	16	17	18	19	22	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):